500 results on '"Mollapour, Mehdi"'
Search Results
2. Second international symposium on the chaperone code, 2023
3. Editorial : A new chapter for Cell Stress and Chaperones
4. Catalytic inhibitor of Protein Phosphatase 5 activates the extrinsic apoptotic pathway by disrupting complex II in kidney cancer.
5. Second Virtual International Symposium on Cellular and Organismal Stress Responses, September 8–9, 2022
6. Impact of Co-chaperones and Posttranslational Modifications Toward Hsp90 Drug Sensitivity
7. Epichaperomics reveals dysfunctional chaperone protein networks
8. Activation of autophagy depends on Atg1/Ulk1-mediated phosphorylation and inhibition of the Hsp90 chaperone machinery
9. PhosY-secretome profiling combined with kinase-substrate interaction screening defines active c-Src-driven extracellular signaling
10. Detecting Posttranslational Modifications of Hsp90 Isoforms
11. Hsp90 chaperone code and the tumor suppressor VHL cooperatively regulate the mitotic checkpoint
12. Impact of Co-chaperones and Posttranslational Modifications Toward Hsp90 Drug Sensitivity
13. A specialized Hsp90 co-chaperone network regulates steroid hormone receptor response to ligand
14. Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma
15. First Virtual International Congress on Cellular and Organismal Stress Responses, November 5–6, 2020
16. Structure and function of the co-chaperone protein phosphatase 5 in cancer
17. MMPs, tyrosine kinase signaling and extracellular matrix proteolysis in kidney cancer
18. The Role of Heat Shock Protein-90 in the Pathogenesis of Birt-Hogg-Dubé and Tuberous Sclerosis Complex Syndromes
19. The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect
20. Post-translational modifications of Hsp90 and translating the chaperone code
21. The HSP90 chaperone code regulates the crosstalk between proteostasis and autophagy
22. Activation of autophagy depends on Atg1/Ulk1-mediated phosphorylation and inhibition of the Hsp90 chaperone machinery
23. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Matrix Proteolysis
24. Post-translational Regulation of FNIP1 Creates a Rheostat for the Molecular Chaperone Hsp90
25. The mTOR Independent Function of Tsc1 and FNIPs
26. Extracellular Phosphorylation of TIMP-2 by Secreted c-Src Tyrosine Kinase Controls MMP-2 Activity
27. The multiple facets of the Hsp90 machine
28. Saccharomyces cerevisiae as a tool for deciphering Hsp90 molecular chaperone function
29. Phosphorylation and Ubiquitination Regulate Protein Phosphatase 5 Activity and Its Prosurvival Role in Kidney Cancer
30. Malignant epithelioid angiomyolipoma (eAML)/PEComa of the kidney: A genomic landscape study.
31. Fanconi anemia complementation group C (FANCC) gene association with hereditary and sporadic renal tumors (RT).
32. Comprehensive genomic profiling of histologic subtypes of urethral carcinomas
33. Molecular genetic analysis of preservative resistance in Zygosaccharomyces bailii
34. Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma
35. Faculty Opinions recommendation of Lactate regulates cell cycle by remodelling the anaphase promoting complex.
36. Faculty Opinions recommendation of Single-cell intracellular pH dynamics regulate the cell cycle by timing the G1 exit and G2 transition.
37. MP04-12 PHARMACOLOGICAL INHIBITION OF THE MOLECULAR CHAPERONE HSP70 OVERCOMES BELZUTIFAN RESISTANCE IN CCRCC
38. MP04-09 NOVEL INHIBITOR OF PRO-SURVIVAL PROTEIN PHOSPHATASE 5 (PP5) LEADS TO APOPTOSIS IN CLEAR CELL RENAL CELL CARCINOMA
39. Second Virtual International Symposium on Cellular and Organismal Stress Responses, September 8–9, 2022 [Meeting Review]
40. Chromophobe Renal Cell Carcinoma is the Most Common Nonclear Renal Cell Carcinoma in Young Women: Results from the SEER Database
41. Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors
42. Structural and functional basis of protein phosphatase 5 substrate specificity
43. Supplementary Figure 4 from The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
44. Supplementary Figure 1 from The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
45. Supplementary Figure Legend from The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
46. Supplementary Table 1 from The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
47. Supplementary Figure 3 from The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
48. Data from The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
49. Supplementary Figure 5 from The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
50. Supplementary Table 2 from The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.